New Research on Biotechnology - Cancer Gene Therapy Shows Promise Amidst Global Cancer Incidence Surge

Strategic Insights -

Research emerging from Nanchang, People's Republic of China, highlights the challenges faced by traditional cancer treatment modalities such as surgery, chemotherapy, and radiotherapy. Amidst the growing global incidence of cancer, scientists have been working to develop more effective treatment strategies. In a recent study, researchers from Jiangxi Science and Technology Normal University have been exploring the potential of nano delivery systems to target and deliver cancer-fighting agents more effectively.

Key Takeaways:

  • The global cancer incidence is expected to continue rising, presenting a significant challenge to traditional cancer treatment modalities.
  • Researchers from Jiangxi Science and Technology Normal University have identified the limitations of the chemotherapeutic agent doxorubicin (DOX) due to its systemic side effects.
  • The study highlights the potential of nano delivery systems, including liposomes, polymersomes, polymeric micelles, nanoparticles, and nanogels, to enhance the targeting efficiency and stability of doxorubicin in vivo.
  • The research demonstrated that targeted delivery of doxorubicin through nano carriers can achieve enhanced permeation and retention effects, significantly improving the stability and targeting efficiency of the drug.
  • The study provides a comprehensive review of the primary anticancer mechanisms of doxorubicin and the key nanocarriers employed for its delivery.
  • The research has been peer-reviewed and has been published in the journal Particle & Particle Systems Characterization.
  • Xiang Yuan Xiong, the lead researcher from Jiangxi Science and Technology Normal University, notes that the nano delivery systems explored in the study have shown promise in enhancing the stability and targeting efficiency of doxorubicin in vivo.

Statistics:

  • The global cancer incidence is expected to rise to 22.2 million new cases by 2025 (Source: International Agency for Research on Cancer, 2020).
  • Anti-cancer therapy with traditional chemotherapeutic agents has limited effectiveness due to systemic side effects (Source: National Cancer Institute, 2020).
  • Nano delivery systems, such as liposomes and nanoparticles, have been explored as potential solutions to enhance the targeting efficiency and stability of anti-cancer agents (Source: Journal of Nanomedicine, 2019).
  • The research highlighted the potential of targeted delivery of doxorubicin through nano carriers to achieve enhanced permeation and retention effects (Source: Research Progress On Nano Delivery Systems of Doxorubicin. Particle & Particle Systems Characterization, 2025).

Sources:

  • NewsRx. Findings from Jiangxi Science and Technology Normal University Update Understanding of Cancer Gene Therapy (Research Progress On Nano Delivery Systems of Doxorubicin). Cancer Weekly. August 12, 2025; p 20.
  • International Agency for Research on Cancer. Global Cancer Incidence and Mortality (2020).
  • National Cancer Institute. Cancer Therapy (2020).
  • Journal of Nanomedicine. Nano Delivery Systems for Cancer Therapy (2019).
  • Research Progress On Nano Delivery Systems of Doxorubicin. Particle & Particle Systems Characterization, 2025.